Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | HBB | P68871 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8088381 | 1.00 | PNP (0.59) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL27093634 | 1.00 | PNP (0.59) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983833 | 0.89 | ADORA3 (0.67) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983838 | 0.89 | ADORA3 (0.67) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL23352546 | 0.85 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL657819 | 0.85 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL21162582 | 0.85 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL29502677 | 0.85 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL17521211 | 0.85 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL9141685 | 0.85 | PNP (0.62) | PNPLMNATP53HTTPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4323517-A2 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS | Sixfold Bioscience Ltd. (GB) | 2024-02-21 | — | — | EP | claimed |
| EP-4323517-A2 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS | Sixfold Bioscience Ltd. (GB) | 2024-02-21 | — | — | EP | disclosed |
| US-9670540-B2 | Methods and devices for DNA sequencing and molecular diagnostics | CORNELL UNIVERSITY (US) | 2017-06-06 | — | — | US | disclosed |
| US-20150099642-A1 | METHODS AND DEVICES FOR DNA SEQUENCING AND MOLECULAR DIAGNOSTICS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2015-04-09 | — | — | US | disclosed |
| WO-2013012440-A2 | METHODS AND DEVICES FOR DNA SEQUENCING AND MOLECULAR DIAGNOSTICS | CORNELL UNIVERSITY (US) | 2013-01-24 | — | — | WO | disclosed |
| EP-1151093-A4 | ISOLATION OF NUCLEIC ACID MOLECULES | INVITROGEN CORP (US) | 2003-01-08 | — | — | EP | disclosed |
| WO-2000046366-A9 | ISOLATION OF NUCLEIC ACID MOLECULES | INVITROGEN CORP (US) | 2002-02-14 | — | — | WO | disclosed |
| EP-1151093-A1 | ISOLATION OF NUCLEIC ACID MOLECULES | INVITROGEN CORPORATION (US) | 2001-11-07 | — | — | EP | disclosed |
| EP-0866796-B1 | IMPROVEMENTS IN OR RELATING TO MUTAGENESIS OF NUCLEIC ACIDS | AMERSHAM PHARM BIOTECH UK LTD (GB) | 2000-11-29 | — | — | EP | disclosed |
| WO-2000046366-A1 | ISOLATION OF NUCLEIC ACID MOLECULES | INVITROGEN CORPORATION (US) | 2000-08-10 | — | — | WO | disclosed |